New Delhi: Docon Technologies, one of the promoters of Thyrocare Technologies, on Friday divested a 10 per cent stake in the diagnostics chain for Rs 667 crore through an open market transaction.

According to the bulk deal data on the National Stock Exchange (NSE), Docon Technologies offloaded a little over 53.32 lakh shares, or 10.06 per cent stake, in the company.

The transaction was valued at around Rs 667.69 crore, and was executed at an average price of Rs 1,252.03 apiece.

After the stake sale, Docon Technologies' holding in Thyrocare Technologies has come down to 61 per cent from 71.06 per cent.

Meanwhile, ICICI Prudential Mutual Fund (MF), Aditya Birla Sun Life MF, HDFC MF, HSBC MF, Eastspring Investments collectively purchased 42.11 lakh shares, or 7.95 per cent stake, at an av

See Full Page